Site-specific therapy guided by a 90-gene expression assay versus empirical chemotherapy in patients with cancer of unknown primary (Fudan CUP-001): a randomised controlled trial by Liu, Xin, MD, Zhang, Xiaowei, MD, Jiang, Shiyu, MD, Mo, Miao, MM, Wang, Qifeng, MD, Wang, Yanli, MM, Zhou, Liangping, MD, Hu, Silong, MD, Yang, Huijuan, Prof, Hou, Yifeng, MD, Chen, Yong, Prof, Lu, Xueguan, MD, Wang, Yu, MD, Zhou, Xiaoyan, Prof, Li, Wentao, MD, Chang, Cai, Prof, Yang, Xiujiang, MD, Chen, Ke, MD, Cao, Jun, MD, Xu, Qinghua, PhD, Sun, Yifeng, MSc, Luo, Jianfeng, MD PhD, Luo, Zhiguo, MD, Hu, Xichun, Prof

Get full text

The impact of endovascular treatment on clinical outcomes of stable symptomatic patients with spontaneous superior mesenteric artery dissection by Gao, Peixian, PhD, MD, Li, Gang, MD, Chen, Jianfeng, MD, Qiu, Renfeng, MD, Qiao, Changyu, MD, Luo, Kun, MD, Chen, Shuxiao, MD, Wu, Xuejun, MD, Dong, Dianning, MD

Get full text